| [1] |
KATSIPOULAKI M, STAPPERS MHT, MALAVIA-JONES D, et al. Candida albicans and Candida glabrata: global priority pathogens[J]. Microbiol Mol Biol Rev, 2024, 88(2):e0002123.
doi: 10.1128/mmbr.00021-23
URL
|
| [2] |
KRCMERY V, BARNESA J. Non-albicans Candida spp. causing fungaemia: pathogenicity and antifungal resistance[J]. J Hosp Infect, 2002, 50(4):243-260.
doi: 10.1053/jhin.2001.1151
URL
|
| [3] |
FRÍAS-DE-LEÓN M G, HERNÁNDEZ-CASTRO R, CONDE-CUEVAS E, et al. Candida glabrata antifungal resistance and virulence factors, a perfect pathogenic combination[J]. Pharmaceutics, 2021, 13(10):1529.
doi: 10.3390/pharmaceutics13101529
URL
|
| [4] |
DE GROOT P W, KRANEVELD E A, YIN Q Y, et al. The cell wall of the human pathogen Candida glabrata: differential incorporation of novel adhesin-like wall proteins[J]. Eukaryot Cell, 2008, 7(11):1951-1964.
doi: 10.1128/EC.00284-08
URL
|
| [5] |
王鲁灵, 刘锦燕, 赵珺涛, 等. 光滑念珠菌毒力因子Epa黏附素的研究进展[J]. 中国真菌学杂志, 2024, 19(3): 320-324.
|
|
WANG L L, LIU J Y, ZHAO J T, et al. Research progress on Epa adhesins, the virulence factors of Candida glabrata[J]. Chin J Mycol, 2024, 19(3):320-324.
|
| [6] |
ZHAO J T, CHEN K Z, LIU J Y, et al. FLO8 deletion leads to decreased adhesion and virulence with down-regulated expression of EPA1, EPA6, and EPA7 in Candida glabrata[J]. Braz J Microbiol, 2022, 53(2):727-738.
doi: 10.1007/s42770-022-00703-7
|
| [7] |
WANG L L, HUANG S J, ZHAO J T, et al. Regulatory role of Mss11 in Candida glabrata virulence: adhesion and biofilm formation[J]. Front Cell Infect Microbiol, 2024, 4:13:1321094.
|
| [8] |
王钰婷, 刘锦燕, 史册, 等. 白念珠菌ERG3基因敲除及其对耐药性的影响[J]. 上海交通大学学报(医学版), 2020, 40(2):163-170.
|
|
WANG Y T, LIU J Y, SHI C, et al. Knocking out ERG3 gene of Candida albicans and its effect on drug resistanc[J]. J Shanghai Jiao Tong Univ (Med Sci), 2020, 40(2):163-170.
|
| [9] |
赵珺涛, 袁捷, 刘锦燕, 等. 运用融合PCR技术敲除光滑念珠菌FLO8基因以及其对EPA黏附素家族表达的影响[J]. 诊断学理论与实践, 2024, 23(4): 398-404.
|
|
ZHAO J T, YUAN J, LIU J Y, et al. Knocking out FLO8 gene of Candida glabrata and its effect on EPA family[J]. J Diagn Concepts Pract, 2024, 23(4): 398-404.
|
| [10] |
UENO K, UNO J, NAKAYAMA H, et al. Development of a highly efficient gene targeting system induced by transient repression of YKU80 expression in Candida glabrata[J]. Eukaryot Cell, 2007, 6(7):1239-1247.
doi: 10.1128/EC.00414-06
URL
|
| [11] |
MÉTIVIER K, ZHOU-LI Y, FAIRHEAD C. In vivo CRISPR-Cas 9 expression in Candida glabrata, Candida bracarensis, and Candida nivariensis: A versatile tool to study chromosomal break repair[J]. Yeast, 2024, 41(9):560-567.
doi: 10.1002/yea.v41.9
URL
|
| [12] |
SHEN J, GUO W, KÖHLER J R. CaNAT1, a heterologous dominant selectable marker for transformation of Candida albicans and other pathogenic Candida species[J]. Infect Immun, 2005, 73(2):1239-1242.
doi: 10.1128/IAI.73.2.1239-1242.2005
URL
|
| [13] |
BASSO LR J R, BARTISS A, MAO Y, et al. Transformation of Candida albicans with a synthetic hygromycin B resistance gene[J]. Yeast, 2010, 27(12):1039-1048.
doi: 10.1002/yea.v27.12
URL
|
| [14] |
ESSEN L O, VOGT M S, MÖSCH H U. Diversity of GPI-anchored fungal adhesions[J]. Biol Chem, 2020, 401(12):1389-1405.
doi: 10.1515/hsz-2020-0199
URL
|
| [15] |
PAULITSCH A H, WILLINGER B, ZSALATZ B, et al. In-vivo Candida biofilms in scanning electron microscopy[J]. Med Mycol, 2009, 47(7):690-696.
doi: 10.3109/13693780802635237
URL
|
| [16] |
GALOCHA M, PAIS P, CAVALHEIRO M, et al. Divergent approaches to virulence in C. albicans and C. glabrata: Two sides of the same coin[J]. Int J Mol Sci, 2019, 20(9):2345.
doi: 10.3390/ijms20092345
URL
|